Schedule 13D ownership disclosure
KINIKSA PHARMACEUTICALS LTD
Security class unavailable · CUSIP: G5269C101
Event date: 2020-05-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,874,617
- Percent of class
- 11.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-063267
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- May 18, 2020
- Reporting period
- May 13, 2020
- Description
- Schedule 13D beneficial ownership